These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 22792665)

  • 41. Drug distribution and the physician's responsibilities.
    Golden M
    Del Med J; 1984 Oct; 56(10):593-6. PubMed ID: 6500104
    [No Abstract]   [Full Text] [Related]  

  • 42. Authority for practitioners to dispense or prescribe approved narcotic controlled substances for maintenance or detoxification treatment. Final rule.
    Drug Enforcement Administration (DEA), Justice
    Fed Regist; 2005 Jun; 70(120):36338-44. PubMed ID: 15973789
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Data silos impede progress against prescription drug abuse.
    Traynor K
    Am J Health Syst Pharm; 2012 Apr; 69(8):628, 630, 632. PubMed ID: 22472861
    [No Abstract]   [Full Text] [Related]  

  • 44. Controlled substances in long-term care pharmacy: part 2.
    Martin CM
    Consult Pharm; 2008 Oct; 23(10):742-56. PubMed ID: 19032014
    [TBL] [Abstract][Full Text] [Related]  

  • 45. States respond to growing abuse of painkiller.
    Wasserman S
    State Legis; 2001; 27(9):33-4. PubMed ID: 11763873
    [TBL] [Abstract][Full Text] [Related]  

  • 46. ASHP technical assistance bulletin on institutional use of controlled substances.
    Am J Hosp Pharm; 1987 Mar; 44(3):580-9. PubMed ID: 3565417
    [No Abstract]   [Full Text] [Related]  

  • 47. Liability for overprescription of controlled substances. Can it be justified in light of the current practice of undertreating pain?
    Nist JB
    J Leg Med; 2002 Mar; 23(1):85-113. PubMed ID: 11957333
    [No Abstract]   [Full Text] [Related]  

  • 48. From balanced pain care to drug trafficking: the case of Dr. William Hurwitz and the DEA.
    Fishman SM
    Pain Med; 2005; 6(2):162-4. PubMed ID: 15773882
    [No Abstract]   [Full Text] [Related]  

  • 49. Responsible prescribing of controlled substances.
    Voth EA; Dupont RL; Voth HM
    Am Fam Physician; 1991 Nov; 44(5):1673-8. PubMed ID: 1950964
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Drug-abuse deterrent formulations.
    Wick JY
    Consult Pharm; 2009 May; 24(5):356-62, 365. PubMed ID: 19555144
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prescription opiate medications: medical uses and consequences, laws and controls.
    Miller NS
    Psychiatr Clin North Am; 2004 Dec; 27(4):689-708. PubMed ID: 15550288
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prescribing Schedule 8 drugs.
    Bird S
    Aust Fam Physician; 2006; 35(1-2):59-60. PubMed ID: 16489388
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dangers of self-prescribing and prescribing for family members.
    Price M; McIntyre BW
    Med Health R I; 2007 Jun; 90(6):178-81. PubMed ID: 17633590
    [No Abstract]   [Full Text] [Related]  

  • 54. Wanted: unwanted Rx for a safe and healthy West Virginia.
    Romero R
    W V Med J; 2013; 109(1):47. PubMed ID: 23413547
    [No Abstract]   [Full Text] [Related]  

  • 55. Is the DEA's new "prescription series" regulation balanced?
    Gilson AM; Joranson DE
    J Pain Palliat Care Pharmacother; 2008; 22(3):218-20. PubMed ID: 19042852
    [TBL] [Abstract][Full Text] [Related]  

  • 56. There ought to be a law.
    Gordon JB
    West J Med; 1990 Sep; 153(3):331. PubMed ID: 2219908
    [No Abstract]   [Full Text] [Related]  

  • 57. Electronic prescription monitoring. Policy statement.
    American College of Emergency Physicians
    Ann Emerg Med; 2012 Mar; 59(3):241-2. PubMed ID: 22340811
    [No Abstract]   [Full Text] [Related]  

  • 58. Out of the medicine closet: time to talk straight about prescription drug abuse.
    Haller C; James L
    Clin Pharmacol Ther; 2010 Sep; 88(3):279-82. PubMed ID: 20725072
    [No Abstract]   [Full Text] [Related]  

  • 59. Drugs, doctors and the Controlled Substances Act.
    Boyle TP
    J Kans Dent Assoc; 1994 Jan; 79(1):42, 45. PubMed ID: 8064514
    [No Abstract]   [Full Text] [Related]  

  • 60. Regulatory controversy surrounding ipecac use and misuse.
    Brushwood DB; Tietze KJ
    Am J Hosp Pharm; 1986 Jan; 43(1):157-61. PubMed ID: 2869686
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.